Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Effects of anti-aIIb mediated FNAIT in placenta pathology and angiogenesis
FY 2016-17
Summary
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a life-threatening bleeding disorder that affects newborns and fetuses. FNAIT can cause bleeding, neurological impairment and even death. It develops during pregnancy if the mother’s immune system produces antibodies that attack the baby’s platelets (cell fragments essential in blood clotting). The antibodies attack specific labels, known as antigens on the baby’s platelets that were inherited from its father, most commonly ?3 and ?IIb surface proteins. These antigens may also be expressed in the placenta on cells lining blood vessels (endothelial cells), blood stem cells (hematopoietic stem cells) and trophoblast cells which help anchor the embryo/fetus and develop its blood supply. We recently discovered that antibodies targeting ?3 can impair blood vessel growth which was the major cause of bleeding in FNAIT. Little research has been done on the effects of ?IIb antibodies on placenta blood vessels nor do we understand which placenta cells express ?IIb. ?IIb-mediated FNAIT will be induced in mice and advanced imaging techniques will be used to measure placenta blood vessel growth and fetal health in both healthy and FNAIT-affected mice. After obtaining placentas from both groups, levels of actively dividing cells (a sign of blood vessel growth and placenta health) as well as endothelial cells, trophoblasts and hematopoietic stem cells will be measured using immunofluorescence. Healthy placental cells will be isolated to identify which cell types can express ?IIb and therefore which cells can be directly affected by ?IIb antibodies. This research will improve our understanding of FNAIT and aid in the development of novel treatments to save fetus and newborn lives.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367343
Name
Sullivan Jade A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effects of anti-aIIb mediated FNAIT in placenta pathology and angiogenesis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alphaiib; Angiogenesis; Endothelial Cells; Fetal/Neonatal Alloimmune Thrombocytopenia; Hematopoeitic Stem Cells; Mouse Model; Placenta; Trophoblasts
Abstract
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a life-threatening bleeding disorder that affects newborns and fetuses. FNAIT can cause bleeding, neurological impairment and even death. It develops during pregnancy if the mother’s immune system produces antibodies that attack the baby’s platelets (cell fragments essential in blood clotting). The antibodies attack specific labels, known as antigens on the baby’s platelets that were inherited from its father, most commonly ?3 and ?IIb surface proteins. These antigens may also be expressed in the placenta on cells lining blood vessels (endothelial cells), blood stem cells (hematopoietic stem cells) and trophoblast cells which help anchor the embryo/fetus and develop its blood supply. We recently discovered that antibodies targeting ?3 can impair blood vessel growth which was the major cause of bleeding in FNAIT. Little research has been done on the effects of ?IIb antibodies on placenta blood vessels nor do we understand which placenta cells express ?IIb. ?IIb-mediated FNAIT will be induced in mice and advanced imaging techniques will be used to measure placenta blood vessel growth and fetal health in both healthy and FNAIT-affected mice. After obtaining placentas from both groups, levels of actively dividing cells (a sign of blood vessel growth and placenta health) as well as endothelial cells, trophoblasts and hematopoietic stem cells will be measured using immunofluorescence. Healthy placental cells will be isolated to identify which cell types can express ?IIb and therefore which cells can be directly affected by ?IIb antibodies. This research will improve our understanding of FNAIT and aid in the development of novel treatments to save fetus and newborn lives.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sullivan, Jade A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~